CELZ
Price
$2.65
Change
-$0.14 (-5.02%)
Updated
Jun 27 closing price
Capitalization
6.84M
RIGL
Price
$19.46
Change
+$0.70 (+3.73%)
Updated
Jun 27 closing price
Capitalization
348.15M
Interact to see
Advertisement

CELZ vs RIGL

Header iconCELZ vs RIGL Comparison
Open Charts CELZ vs RIGLBanner chart's image
Creative Medical Technology Holdings
Price$2.65
Change-$0.14 (-5.02%)
Volume$59.2K
Capitalization6.84M
Rigel Pharmaceuticals
Price$19.46
Change+$0.70 (+3.73%)
Volume$551.16K
Capitalization348.15M
CELZ vs RIGL Comparison Chart in %
Loading...
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELZ vs. RIGL commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELZ is a Buy and RIGL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CELZ: $2.65 vs. RIGL: $19.46)
Brand notoriety: CELZ and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELZ: 110% vs. RIGL: 270%
Market capitalization -- CELZ: $6.84M vs. RIGL: $348.15M
CELZ [@Biotechnology] is valued at $6.84M. RIGL’s [@Biotechnology] market capitalization is $348.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELZ’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • CELZ’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, CELZ is a better buy in the long-term than RIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELZ’s TA Score shows that 5 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • CELZ’s TA Score: 5 bullish, 4 bearish.
  • RIGL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CELZ is a better buy in the short-term than RIGL.

Price Growth

CELZ (@Biotechnology) experienced а +7.29% price change this week, while RIGL (@Biotechnology) price change was +2.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RIGL($348M) has a higher market cap than CELZ($6.84M). RIGL YTD gains are higher at: 15.696 vs. CELZ (14.719). RIGL has higher annual earnings (EBITDA): 48.5M vs. CELZ (-6.17M). RIGL has more cash in the bank: 77.1M vs. CELZ (7.7M). CELZ has less debt than RIGL: CELZ (2.74M) vs RIGL (61.1M). RIGL has higher revenues than CELZ: RIGL (203M) vs CELZ (14K).
CELZRIGLCELZ / RIGL
Capitalization6.84M348M2%
EBITDA-6.17M48.5M-13%
Gain YTD14.71915.69694%
P/E RatioN/A9.32-
Revenue14K203M0%
Total Cash7.7M77.1M10%
Total Debt2.74M61.1M4%
FUNDAMENTALS RATINGS
CELZ vs RIGL: Fundamental Ratings
CELZ
RIGL
OUTLOOK RATING
1..100
5071
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
77
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
4241
P/E GROWTH RATING
1..100
65100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CELZ's Valuation (64) in the null industry is in the same range as RIGL (77) in the Biotechnology industry. This means that CELZ’s stock grew similarly to RIGL’s over the last 12 months.

CELZ's Profit vs Risk Rating (100) in the null industry is in the same range as RIGL (100) in the Biotechnology industry. This means that CELZ’s stock grew similarly to RIGL’s over the last 12 months.

CELZ's SMR Rating (98) in the null industry is in the same range as RIGL (100) in the Biotechnology industry. This means that CELZ’s stock grew similarly to RIGL’s over the last 12 months.

RIGL's Price Growth Rating (41) in the Biotechnology industry is in the same range as CELZ (42) in the null industry. This means that RIGL’s stock grew similarly to CELZ’s over the last 12 months.

CELZ's P/E Growth Rating (65) in the null industry is somewhat better than the same rating for RIGL (100) in the Biotechnology industry. This means that CELZ’s stock grew somewhat faster than RIGL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELZRIGL
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 14 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
CELZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOELY95.753.24
+3.50%
Tokyo Electron Ltd.
CGGGF1.110.03
+3.00%
Coats Group PLC
AHEXF25.86N/A
N/A
Adecco Group AG
ALLDF8.25N/A
N/A
ALD S A
ELRFF0.21-0.01
-3.64%
Eastern Platinum Ltd.

CELZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELZ has been loosely correlated with HOOK. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CELZ jumps, then HOOK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELZ
1D Price
Change %
CELZ100%
-5.02%
HOOK - CELZ
41%
Loosely correlated
N/A
DARE - CELZ
41%
Loosely correlated
-10.08%
RIGL - CELZ
40%
Loosely correlated
+3.73%
AZTR - CELZ
37%
Loosely correlated
-0.69%
PHIO - CELZ
35%
Loosely correlated
-1.81%
More

RIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, RIGL has been closely correlated with CLNN. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if RIGL jumps, then CLNN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RIGL
1D Price
Change %
RIGL100%
+3.73%
CLNN - RIGL
92%
Closely correlated
-4.08%
DARE - RIGL
88%
Closely correlated
-10.08%
PHIO - RIGL
84%
Closely correlated
-1.81%
AZTR - RIGL
84%
Closely correlated
-0.69%
IMRN - RIGL
82%
Closely correlated
-1.60%
More